Trial Profile
A Phase 1, Open-Label, 2-Cohort Study to Assess the Single Dose Pharmacokinetics of Two Formulations of TD-1473 and to Assess the Effect of a High-Fat Meal and Itraconazole on the Pharmacokinetics of TD-1473 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Jan 2020
Price :
$35
*
At a glance
- Drugs Izencitinib (Primary) ; Itraconazole
- Indications Gastrointestinal disorders; Ulcerative colitis
- Focus Pharmacokinetics
- Sponsors Theravance Biopharma
- 06 Sep 2018 Status changed from not yet recruiting to completed.
- 20 Jun 2018 New trial record